FR2018062B1 - - Google Patents
Info
- Publication number
- FR2018062B1 FR2018062B1 FR6931141A FR6931141A FR2018062B1 FR 2018062 B1 FR2018062 B1 FR 2018062B1 FR 6931141 A FR6931141 A FR 6931141A FR 6931141 A FR6931141 A FR 6931141A FR 2018062 B1 FR2018062 B1 FR 2018062B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/12—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
- C07C259/18—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4362868 | 1968-09-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2018062A1 FR2018062A1 (en) | 1970-05-29 |
FR2018062B1 true FR2018062B1 (en) | 1974-01-11 |
Family
ID=10429626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR6931141A Expired FR2018062B1 (en) | 1968-09-13 | 1969-09-12 |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE738831A (en) |
DE (1) | DE1946638A1 (en) |
FR (1) | FR2018062B1 (en) |
GB (1) | GB1227978A (en) |
NL (1) | NL6913673A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58150576A (en) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | Novel 1,2,4-oxadiazole derivatives |
US4562186A (en) * | 1985-01-22 | 1985-12-31 | Hoechst-Roussel Pharmaceuticals Inc. | (1,2,4-Oxadiazol-3-yl)arylmethanones, compositions and pharmaceutical use |
JP2002508323A (en) * | 1997-12-17 | 2002-03-19 | メルク エンド カムパニー インコーポレーテッド | Integrin receptor antagonist |
CA3170273A1 (en) | 2020-03-17 | 2021-09-23 | Sumitomo Pharma Co., Ltd. | Oxadiazole derivative |
-
1968
- 1968-09-13 GB GB1227978D patent/GB1227978A/en not_active Expired
-
1969
- 1969-09-09 NL NL6913673A patent/NL6913673A/xx unknown
- 1969-09-12 BE BE738831D patent/BE738831A/xx unknown
- 1969-09-12 FR FR6931141A patent/FR2018062B1/fr not_active Expired
- 1969-09-15 DE DE19691946638 patent/DE1946638A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
DE1946638A1 (en) | 1970-09-03 |
GB1227978A (en) | 1971-04-15 |
NL6913673A (en) | 1970-03-17 |
BE738831A (en) | 1970-03-12 |
FR2018062A1 (en) | 1970-05-29 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |